Viewing Study NCT04885634

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-02-23 @ 11:34 AM
Study NCT ID: NCT04885634
Status: WITHDRAWN
Last Update Posted: 2023-11-03
First Post: 2021-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
Sponsor: Axel Brandes
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation View
None Overweight and Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atrial fibrillation View
None Overweight View
None Obesity View
None Semaglutide View
None Glucagon-like peptide-1 (GLP-1) receptor agonist View
None Implantable cardiac monitor View